REGENERATIVE MEDICAL TECHNOLOGY GROUP INC. (MSSV) Financial Statements (2025 and earlier)

Company Profile

Business Address 433 PLAZA REAL SUITE 275
BOCA RATON, FL 33432
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 599 - Retail Stores, Not Elsewhere Classified (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 579531   
Cash and cash equivalents 579531   
Receivables2444243551103
Inventory, net of allowances, customer advances and progress billings7     
Inventory7     
Prepaid expense394621112211
Deferred costs 8  243341
Other undisclosed current assets609  1,1201,1711,585
Total current assets:6876685751,1901,2761,739
Noncurrent Assets
Operating lease, right-of-use asset1081253111926
Property, plant and equipment360366359148131160
Intangible assets, net (including goodwill)1,8881,9121,9371,9616,1116,135
Goodwill1,6801,6801,6801,6805,8055,805
Intangible assets, net (excluding goodwill)208232257281305330
Other noncurrent assets776   
Other undisclosed noncurrent assets (0)  666
Total noncurrent assets:2,3642,4112,3042,1256,2666,327
TOTAL ASSETS:3,0503,0792,8793,3157,5428,066
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5627,9187,0197,4486,5755,805
Accounts payable 555421367337374
Accrued liabilities8,1307,3646,5977,0816,2385,431
Other undisclosed accounts payable and accrued liabilities (7,568)     
Deferred revenue373     
Debt17,27116,24415,22416,9707,0947,070
Derivative instruments and hedges, liabilities4     
Other undisclosed current liabilities8,2071957152352
Total current liabilities:26,41724,35722,24924,43313,69212,927
Noncurrent Liabilities
Long-term debt and lease obligation40  888,756
Long-term debt, excluding current maturities40  888,756
Liabilities, other than long-term debt3249   5
Operating lease, liability3249    
Derivative instruments and hedges, liabilities      5
Other undisclosed noncurrent liabilities2,3942,4302,4254139,52631
Total noncurrent liabilities:2,4672,4792,4254219,5338,792
Total liabilities:28,88326,83624,67524,85523,22521,719
Equity
Equity, attributable to parent, including:(25,833)(23,757)(21,796)(21,540)(15,683)(13,653)
Preferred stock      1
Common stock121212121212
Additional paid in capital40,18140,18140,18140,18140,18140,181
Accumulated deficit(66,028)(63,951)(61,990)(61,734)(55,877)(53,847)
Other undisclosed equity, attributable to parent111110
Other undisclosed equity   0   
Total equity:(25,833)(23,757)(21,796)(21,540)(15,683)(13,653)
TOTAL LIABILITIES AND EQUITY:3,0503,0792,8793,3157,5428,066

Income Statement (P&L) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Revenues793817616647361786
Cost of revenue(266)(248)(181)(197)(108)(249)
Other undisclosed gross profit   (0)0  
Gross profit:527569435450254537
Operating expenses(741)(674)(570)(525)(685)(611)
Other operating expense, net
(Other Expenses)
      (504)
Operating income (loss):(214)(105)(135)(75)(431)(578)
Nonoperating expense  (1,635)(1,658)(1,600)(1,598)
Investment income, nonoperating   (6,495)  2
Other nonoperating income (expense)   4,861(1,658)(1,600)(1,600)
Interest and debt expense  1,509  2
Loss from continuing operations:(214)(105)(261)(1,733)(2,031)(2,174)
Loss from discontinued operations      (0)
Other undisclosed net income   4,125  504
Net income (loss):(214)(105)3,865(1,733)(2,031)(1,670)
Other undisclosed net income (loss) attributable to parent(1,863)(1,856)(4,121)(4,124)1 
Net loss available to common stockholders, diluted:(2,077)(1,961)(256)(5,857)(2,030)(1,670)

Comprehensive Income ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net income (loss):(214)(105)3,865(1,733)(2,031)(1,670)
Comprehensive income (loss), net of tax, attributable to parent:(214)(105)3,865(1,733)(2,031)(1,670)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: